Associate Professor
Harvard Medical School
Boston, Massachusetts
Dr. Castillo was born in Peru, received his medical degree in Mexico City, and completed his Internal Medicine and Hematology & Oncology training at the University of Massachusetts and Brown University, respectively. Dr. Castillo is an Associate Professor at Harvard Medical School and serves as the Clinical Director of the Bing Center for Waldenström Macroglobulinemia at the Dana-Farber Cancer Institute. Dr. Castillo is the principal investigator in a series of innovative clinical trials evaluating highly effective non-chemotherapeutic approaches for patients with Waldenström macroglobulinemia. Dr. Castillo is a member of the NCCN Committee for Myeloma, Amyloidosis and Waldenström Macroglobulinemia. He has authored more than 250 peer-reviewed articles and has published his research in the New England Journal of Medicine, Lancet Oncology, Journal of Clinical Oncology and Blood.
Disclosure information not submitted.
Friday, April 22, 2022
10:50 AM – 12:00 PM
Friday, April 22, 2022
11:20 AM – 11:40 AM
Friday, April 22, 2022
11:40 AM – 12:00 PM
Wednesday, May 11, 2022
12:15 PM – 1:20 PM
Wednesday, May 11, 2022
12:40 PM – 1:00 PM
Wednesday, May 11, 2022
1:00 PM – 1:20 PM